Home
Resources
Follow portfolio news
...

WuXi Biologics confirms its leadership in sustainable development with another listing in the Dow Jones Sustainability 2024 Index

Published on
13/1/2025
Amended on
1/11/2026
0
minute(s)
Odyssey 2021
WuXi Biologics Corporate Building and Entrance Sign
For the second year running, WuXi Biologics achieves global recognition for sustainable practices, consolidating its position as a leader in green biologics solutions. The company has designed a world-leading biologics technology platform, offering integrated end-to-end solutions to support organizations in the development and production of biologics, from conception to commercial manufacturing. WuXi Biologics' unique solutions and technology platforms are designed to help its international customers reduce drug development lead times, cut biologics production costs and offer biomanufacturing partners a reliable, high-performance, high-quality global supply network.
By
Charles Pinsolle
Charles Pinsolle
WuXi Biologics confirms its leadership in sustainable development with another listing in the Dow Jones Sustainability 2024 Index
This article has been automatically translated. Please excuse any inaccuracies or translation errors.
Dieser Artikel wurde automatisch übersetzt. Bitte entschuldigen Sie etwaige Ungenauigkeiten oder Übersetzungsfehler.
This article has been automatically translated. We apologize per inaccuracies or translation errors.

At the top of the sustainability indexes

WuXi Biologics, a company included in theOdyssey Vintage Altaroc Odyssey , has once again been named to the prestigious Dow Jones Sustainability Index (DJSI) for 2024. This recognition reflects the company’s ongoing efforts in sustainability and its significant progress in environmental, social, and governance (ESG) areas.

Launched in 1999, the DJSI is a global benchmark for investors seeking to integrate sustainable practices into their portfolios. The DJSI World index, in particular, comprises the top 10% of the S&P Global Broad Market Index's top 2,500 companies in terms of long-term sustainability.

Chris Chen, CEO of WuXi Biologics and Chairman of the company's ESG Committee, said: "Being included in the DJSI for the second year running is an honor that rewards our ongoing commitment to sustainability. We continue to push the boundaries of innovation to offer sustainable and responsible solutions to our international partners. We remain committed to promoting responsible practices throughout the value chain."

Exemplary ESG performance

WuXi Biologics has won numerous awards for its achievements in sustainable development. The company has also been named one of the United Nations' 20 Examples of Sustainable Development for 20 Years for its innovative eco-friendly biological solutions.

By pursuing its sustainable initiatives, WuXi Biologics affirms its determination to play a central role in the ecological transformation of the biologics industry, while offering innovative and responsible solutions to patients and partners worldwide.

Other content in this topic

Explore our content collections, which bring together different formats around a single subject/issue/theme.
News from the Vintage Altaroc Companies
Follow portfolio news
News from the Vintage Altaroc Companies
Every two weeks, check out the latest announcements from the Vintage Altaroc companies.
Article
|
22
2026-10-22
From elite sports to medical AI: what's new in the portfolio Altaroc
Follow portfolio news
From elite sports to medical AI: what's new in the portfolio Altaroc
Software adopted by every NFL team, AI agents that have already conducted 180 million interactions with patients, and a platform used by nearly one in five Fortune 500 companies. A look at nine acquisitions by the " Vintage "Odyssey over the past three months.
Article
|
19
2026-10-19
Follow portfolio news
News from the Vintage Altaroc Companies
Every two weeks, check out the latest announcements from the Vintage Altaroc companies.
Article
|
08
2026-10-08
A triptych illustrating the sports, health, and business sectors for corporate news from Vintage Altaroc
Follow portfolio news
News from the Vintage Altaroc Companies
Every two weeks, check out the latest announcements from the Vintage Altaroc companies.
Article
|
23
2026-09-23
A triptych illustrating the tech, aerospace, and digital sectors for company news from Vintage Altaroc
Follow portfolio news
News from the Vintage Altaroc Companies
Every two weeks, check out the latest announcements from the Vintage Altaroc companies.
Article
|
07
2026-09-07
Interview with Raul Villar, CEO of Optro
Follow portfolio news
Interview with Raul Villar, CEO of Optro
Raul Villar Jr. unveils his platform's global growth strategy, powered by AI, and his partnership with Hg
Video
|
13
2026-08-13
Interview with Chris Maclin, CEO of Empyrean
Follow portfolio news
Interview with Chris Maclin, CEO of Empyrean
In Boston, Chris Maclin, CEO of Empyrean, explains how his technology platform protects banks and modernizes risk management
Video
|
29
2026-05-29
Interview with Ian Drysdale, CEO of One Inc.
Follow portfolio news
Interview with Ian Drysdale, CEO of One Inc.
Learn about the career of Ian Drysdale, CEO of One Inc, a specialist in payment infrastructure for the insurance industry.
Video
|
09
2026-04-09
Interview with Daniel Baker, CEO of Healthdrive
Follow portfolio news
Interview with Daniel Baker, CEO of Healthdrive
In Boston, Daniel Baker, CEO of HealthDrive, shares his vision for sustainable growth with a human impact.
Video
|
29
2026-01-29
Interview Jeff Wessler - CEO Heartbeat
Follow portfolio news
Interview Jeff Wessler - CEO Heartbeat
Dr. Jeff Wessler, founder of Heartbeat Health, pioneer of virtual-first cardiology in the United States
Video
|
25
2025-11-25
Special report - Focus on the United States: 10 hypergrowth companies
Follow portfolio news
Special report - Focus on the United States: 10 hypergrowth companies
As the historic driving force behind global private equity, the United States is home to some of the most dynamic companies on the planet. This report highlights 10 hyper-growth American companies, backed by private equity, at the heart of key economic sectors.
File
|
12
2024-03-12
No articles in this category yet.
Welcome to Altaroc
In accordance with applicable regulations, we ask that you complete your profile. This step is required to access the content and services offered on our websites.
Please fill out your profile to access the site
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
YOUR INVESTOR PROFILE
Financial intermediary or professional investor
Financial advisors, wealth managers, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced investor or Altaroc investor
Private investors who have already invested with Altaroc or who have a minimum investment capacity of €100,000.
Private investors who have previously invested in Altaroc who have a minimum investment capacity of 200,000 euros.
Non-professional (retail) investor
Individual investors with an investment capacity below €100,000.
Retail investors with an investment capacity of less than 200,000 euros.
Institutional investor
Pension funds, retirement schemes, asset management companies, and single-family offices.
Select your language and investor profile to continue
Select your investor profile to continue
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.